RENEGADE REPORT
CBS MarketWatch - 10 hours ago
... Goodman told the gathering that the company's introduction of a new antidepressant,
Lexapro, has been "one of the most successful product launches in the ...

S&P Ups Forest Labs to Accumulate
BusinessWeek - 03 Jan 2003
... sees earnings per share for the third quarter of fiscal 2003 (March) at least 15%
above the consensus of 77 cents, driven by surging sales of Celexa/Lexapro ...

Home Depot a Party Pooper
Smart Money - 03 Jan 2003
... rose 5% after the company pledged to beat analysts' third-quarter profit projections
by at least 15% thanks to strong sales of mindbenders Celexa and Lexapro. ...

Take a pill to curb shopping urge
Arizona Daily Star, AZ - 03 Jan 2003
... They also began a Forest-funded study testing the effects of its new
antidepressant, Lexapro, on compulsive shopping in December. ...

Take a pill to curb shopping urge
DailyStar.com - 03 Jan 2003
... They also began a Forest-funded study testing the effects of its new
antidepressant, Lexapro, on compulsive shopping in December. ...

Forest Labs Surges on Strong Outlook
TheStreet.com, NY - 02 Jan 2003
... quarter. Sales of the antidepressant Lexapro, launched in September,
should total about $80 million in the quarter, the company said. ...

Forest Labs expects to exceed 3rd-quarter forecast
Forbes - 02 Jan 2003
... will be about $585 million, fueled by projected sales of $370 million for Celexa
and sales of about $80 million for Forest's newer antidepressant, Lexapro ...

Business Briefs
Chicago Sun Times, IL - 17 Dec 2002
... Forest Laboratories Inc., the maker of the Celexa and Lexapro antidepressants, will
split its stock 2-for-1 on Jan. 8 to shareholders of record as of Dec. 23. ...

Forest Laboratories to Split Stock
Newsday - 17 Dec 2002
The Manhattan-based maker of antidepressants Celexa and Lexapro has about
181 million shares outstanding. The new shares will be distributed Jan. ...

Corporate report
Sarasota Herald-Tribune, FL - 17 Dec 2002
... The New York-based maker of antidepressants Celexa and Lexapro has about 181
million shares outstanding. Shares were $98.42, up $1.47. ICT Group Inc. ...

Forest Labs Sets Stock Split
Newsday - 16 Dec 2002
The New York-based maker of antidepressants Celexa and Lexapro has about 181
million shares outstanding. The new shares will be distributed Jan. ...

Drug firms and doctors: the offers pour in
Boston Globe, MA - 15 Dec 2002
... including Forest Pharmaceuticals, which promised the doctors $500 each for listening
to a Saturday morning talk about the firm's new antidepressant, Lexapro ...

RESEARCH ALERT-UBS Warburg cuts Forest Labs
Forbes - 09 Dec 2002
... CJ Sylvester raised his 2003 earnings per share estimate to $3.65 from $3.52 based
on anticipated strong sales of Forest's antidepressants Celexa and Lexapro ...